Structural changes to monomeric CuZn superoxide dismutase caused by the familial amyotrophic lateral sclerosis-associated mutation A4V

Biophysical Journal

Volumn 97, Issue 6, 2009, Pages 1709-1718

  Schmidlin, Tom ^a   Kennedy, Brian K ^a   Daggett, Valerie ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MUTANT PROTEIN; WT1 PROTEIN;

A4V GENE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ENZYME STRUCTURE; FAMILIAL DISEASE; GENE; GENE MUTATION; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; OLIGOMERIZATION; PHENOTYPE; POINT MUTATION; PROTEIN FOLDING; PROTEIN STABILITY; SIMULATION; SOD1 GENE;

EID: 70350023194     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.06.043     Document Type: Article

References (54)

1. Rakhit, R., and A. Chakrabartty. 2006. Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 1762:1025-1037.
2. Pardo, C. A., Z. Xu, D. R. Borchelt, D. L. Price, S. S. Sisodia, et al. 1995. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA. 92:954-958.
3. Rodriguez, J. A., J. S. Valentine, D. K. Eggers, J. A. Roe, A. Tiwari, et al. 2002. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J. Biol. Chem. 277:15932-15937.
4. Lindberg, M. J., L. Tibell, and M. Oliveberg. 2002. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state. Proc. Natl. Acad. Sci. USA. 99:16607-16612.
5. Rodriguez, J. A., B. F. Shaw, A. Durazo, S. H. Sohn, P. A. Doucette, et al. 2005. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 102:10516-10521.
6. Ross, C. A., and M. A. Poirier. 2005. Opinion: what is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell Biol. 6:891-898.
7. Bruijn, L. I., M. K. Houseweart, S. Kato, K. L. Anderson, S. D. Anderson, et al. 1998. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1851-1854.
8. Durham, H. D., J. Roy, L. Dong, and D. A. Figlewicz. 1997. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol. 56:523-530.
9. Johnston, J. A., M. J. Dalton, M. E. Gurney, and R. R. Kopito. 2000. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 97:12571-12576.
10. Valentine, J. S., P. A. Doucette, and S. Zittin Potter. 2005. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 74:563-593.
11. Walsh, D. M., I. Klyubin, J. V. Fadeeva, M. J. Rowan, and D. J. Selkoe. 2002. Amyloid-b oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30:552-557.
12. Khare, S. D., M. Caplow, and N. V. Dokholyan. 2004. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 101:15094-15099.
13. Rakhit, R., J. P. Crow, J. R. Lepock, L. H. Kondejewski, N. R. Cashman, et al. 2004. Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 279:15499-15504.
14. Ray, S. S., R. J. Nowak, K. Strokovich, R. H. Brown, Jr., T. Walz, et al. 2004. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry. 43:4899-4905.
15. Johnston, J. A., and K. Madura. 2004. Rings, chains and ladders: ubiquitin goes to work in the neuron. Prog. Neurobiol. 73:227-257.
16. Sherman, M. Y., and A. L. Goldberg. 2001. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron. 29:15-32.
17. Hough, M. A., J. G. Grossmann, S. V. Antonyuk, R. W. Strange, P. A. Doucette, et al. 2004. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl. Acad. Sci. USA. 101:5976-5981.
18. Chillemi, G., M. Falconi, A. Amadei, G. Zimatore, A. Desideri, et al. 1997. The essential dynamics of Cu, Zn superoxide dismutase: suggestion of intersubunit communication. Biophys. J. 73:1007-1018. (Pubitemid 27337636)
19. Falconi, M., R. Gallimbeni, and E. Paci. 1996. Dimer asymmetry in superoxide dismutase studied by molecular dynamics simulation. J. Comput. Aided Mol. Des. 10:490-498.
20. Khare, S. D., K. C. Wilcox, P. Gong, and N. V. Dokholyan. 2005. Sequence and structural determinants of Cu, Zn superoxide dismutase aggregation. Proteins. 61:617-632. (Pubitemid 41547418)
21. Khare, S. D., F. Ding, and N. V. Dokholyan. 2003. Folding of Cu, Zn superoxide dismutase and familial amyotrophic lateral sclerosis. J. Mol. Biol. 334:515-525.
22. Strange, R. W., C. W. Yong, W. Smith, and S. S. Hasnain. 2007. Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu-Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA. 104:10040-10044.
23. Khare, S. D., and N. V. Dokholyan. 2006. Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants. Proc. Natl. Acad. Sci. USA. 103:3147-3152.
24. Ding, F., and N. V. Dokholyan. 2008. Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation. Proc. Natl. Acad. Sci. USA. 105:19696-19701.
25. Broom, W. J., D. V. Johnson, K. E. Auwarter, A. J. Iafrate, C. Russ, et al. 2008. SOD1A4V-mediated ALS: absence of a closely linked modifier gene and origination in Asia. Neurosci. Lett. 430:241-245.
26. Strange, R. W., S. Antonyuk, M. A. Hough, P. A. Doucette, J. A. Rodriguez, et al. 2003. The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis. J. Mol. Biol. 328:877-891.
27. Beck, D.A.C., Alonso, D.O.V., Daggett, V. 2000-2008. in lucem Molecular Mechanics (ilmm). University of Washington, Seattle, WA.
28. Levitt, M., M. Hirshberg, R. Sharon, and V. Daggett. 1995. Potential energy function and parameters for simulations of the molecular dynamics of proteins and nucleic acids in solution. Comput. Phys. Commun. 91:215-231.
29. Levitt, M., M. Hirshberg, R. Sharon, K. E. Laidig, and V. Daggett. 1997. Calibration and testing of a water model for simulation of the molecular dynamics of proteins and nucleic acids in solution. J. Phys. Chem. B. 101:5051-5061.
30. Beck, D. A., R. S. Armen, and V. Daggett. 2005. Cutoff size need not strongly influence molecular dynamics results for solvated polypeptides. Biochemistry. 44:609-616.
31. Beck, D. A., and V. Daggett. 2004. Methods for molecular dynamics simulations of protein folding/unfolding in solution. Methods. 34:112-120. (Pubitemid 38993212)
32. Armen, R. S., B. M. Bernard, R. Day, D. O. Alonso, and V. Daggett. 2005. Characterization of a possible amyloidogenic precursor in glutamine-repeat neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 102:13433-13438.
33. Kell, G. S. 1967. Precise representation of volume properties of water at one atmosphere. J. Chem. Eng. Data. 12:66-69.
34. Kabsch, W., and C. Sander. 1983. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:2577-2637.
35. Yee, D. P., and K. A. Dill. 1993. Families and the structural relatedness among globular proteins. Protein Sci. 2:884-899.
36. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, et al. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
37. Hayward, L. J., J. A. Rodriguez, J. W. Kim, A. Tiwari, J. J. Goto, et al. 2002. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 277:15923-15931.
38. Crow, J. P., J. B. Sampson, Y. Zhuang, J. A. Thompson, and J. S. Beckman. 1997. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1936-1944.
39. Doucette, P. A., L. J. Whitson, X. Cao, V. Schirf, B. Demeler, et al. 2004. Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability. J. Biol. Chem. 279:54558-54566.
40. Borchelt, D. R., M. K. Lee, H. S. Slunt, M. Guarnieri, Z. S. Xu, et al. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA. 91:8292-8296.
41. Potter, S. Z., H. Zhu, B. F. Shaw, J. A. Rodriguez, P. A. Doucette, et al. 2007. Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. J. Am. Chem. Soc. 129:4575-4583.
42. Mulligan, V. K., A. Kerman, S. Ho, and A. Chakrabartty. 2008. Denaturational stress induces formation of zinc-deficient monomers of cu,zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis. J. Mol. Biol. 383:424-436.
43. Ikeda, M., K. Abe, M. Aoki, M. Sahara, M. Watanabe, et al. 1995. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene. Neurology. 45:2038-2042.
44. Niwa, J., S. Yamada, S. Ishigaki, J. Sone, M. Takahashi, et al. 2007. Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J. Biol. Chem. 282:28087-28095.
45. Banci, L., I. Bertini, A. Durazo, S. Girotto, E. B. Gralla, et al. 2007. Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS. Proc. Natl. Acad. Sci. USA. 104:11263-11267.
46. Cozzolino, M., I. Amori, M. G. Pesaresi, A. Ferri, M. Nencini, et al. 2008. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 283:866-874.
47. Karch, C. M., and D. R. Borchelt. 2008. A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J. Biol. Chem. 283:13528-13537.
48. Richardson, J. S., and D. C. Richardson. 2002. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. USA. 99:2754-2759.
49. Shaw, B. F., A. Durazo, A. M. Nersissian, J. P. Whitelegge, K. F. Faull, et al. 2006. Local unfolding in a destabilized, pathogenic variant of superoxide dismutase 1 observed with H/D exchange and mass spectrometry. J. Biol. Chem. 281:18167-18176.
50. Nordlund, A., and M. Oliveberg. 2006. Folding of Cu/Zn superoxide dismutase suggests structural hotspots for gain of neurotoxic function in ALS: parallels to precursors in amyloid disease. Proc. Natl. Acad. Sci. USA. 103:10218-10223.
51. Armen, R. S., and V. Daggett. 2005. Characterization of two distinct β2-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology. Biochemistry. 44:16098-16107.
52. Armen, R. S., M. L. DeMarco, D. O. Alonso, and V. Daggett. 2004. Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc. Natl. Acad. Sci. USA. 101:11622-11627.
53. Armen, R. S., D. O. Alonso, and V. Daggett. 2004. Anatomy of an amyloidogenic intermediate: conversion of β-sheet to α-sheet structure in transthyretin at acidic pH. Structure. 12:1847-1863. (Pubitemid 39298968)
54. Daggett, V. 2006. α-Sheet: the toxic conformer in amyloid diseases? Acc. Chem. Res. 39:594-602.